By a GenomeWeb staff reporter

NEW YORK (GenomeWeb News) – DNA sequencing developer Nabsys said today that it has reeled in $7 million in Series B venture financing in an equity round led by Stata Venture Partners.

The Providence, RI-based firm said it plans to use the financing to speed up development and commercialization of its core platform, which uses semiconductor technology in a solid-state DNA sequencing tool.

In 2009, Nabsys completed a $4 million equity round.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: association between genome-wide homozygosity and traits like height and cognitive ability, improved CRISPR-Cas9 editing, and more.

A survey examines how age, political leanings, and more influence how Americans view certain scientific topics, the Associated Press reports.

A researcher who pleaded guilty to making false statements in research reports has been sentenced to four and a half years in prison and must pay $7.2 million back to the NIH.

The BabySeq project to study the risks and benefits of sequencing newborns is underway.

Jul
14
Sponsored by
Agilent Technologies

This online seminar will outline a recent example of the use of molecular barcoding in combination with next-generation sequencing to detect somatic mosaicism in cancer patients.